| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Technology, Radiologic | 15 | 2024 | 104 | 4.570 |
Why?
|
| ROC Curve | 31 | 2024 | 781 | 3.700 |
Why?
|
| Radiographic Image Enhancement | 19 | 2022 | 466 | 3.510 |
Why?
|
| Image Processing, Computer-Assisted | 16 | 2024 | 1259 | 3.050 |
Why?
|
| Diagnosis, Computer-Assisted | 19 | 2024 | 332 | 2.950 |
Why?
|
| Tomography, X-Ray Computed | 22 | 2024 | 2692 | 2.900 |
Why?
|
| Societies, Scientific | 5 | 2022 | 42 | 2.540 |
Why?
|
| Radiography, Thoracic | 19 | 2013 | 327 | 2.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 24 | 2013 | 476 | 2.140 |
Why?
|
| Mammography | 14 | 2020 | 468 | 2.050 |
Why?
|
| Radiology | 8 | 2024 | 204 | 1.930 |
Why?
|
| Software | 11 | 2019 | 669 | 1.640 |
Why?
|
| Phantoms, Imaging | 10 | 2023 | 466 | 1.600 |
Why?
|
| Subtraction Technique | 10 | 2013 | 130 | 1.590 |
Why?
|
| Whole Body Imaging | 5 | 2011 | 41 | 1.300 |
Why?
|
| Radiation Dosage | 6 | 2023 | 230 | 1.300 |
Why?
|
| Bone and Bones | 5 | 2011 | 273 | 1.190 |
Why?
|
| Artificial Intelligence | 9 | 2020 | 338 | 1.100 |
Why?
|
| Lung Neoplasms | 18 | 2021 | 2369 | 1.080 |
Why?
|
| Pattern Recognition, Automated | 13 | 2015 | 221 | 1.080 |
Why?
|
| Ultrasonography | 8 | 2016 | 722 | 1.040 |
Why?
|
| Thorax | 2 | 2022 | 77 | 0.940 |
Why?
|
| Computer Simulation | 4 | 2018 | 1103 | 0.930 |
Why?
|
| Diagnostic Imaging | 4 | 2012 | 476 | 0.910 |
Why?
|
| Gallstones | 1 | 2024 | 17 | 0.910 |
Why?
|
| Solitary Pulmonary Nodule | 13 | 2013 | 138 | 0.900 |
Why?
|
| Receptors, Somatostatin | 1 | 2024 | 34 | 0.900 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2019 | 3485 | 0.860 |
Why?
|
| Observer Variation | 25 | 2019 | 615 | 0.860 |
Why?
|
| Radionuclide Imaging | 5 | 2024 | 222 | 0.790 |
Why?
|
| Cholesterol | 1 | 2024 | 362 | 0.780 |
Why?
|
| Liver Neoplasms | 7 | 2016 | 760 | 0.740 |
Why?
|
| Biomedical Research | 3 | 2017 | 403 | 0.740 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2015 | 697 | 0.720 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2020 | 13 | 0.720 |
Why?
|
| Algorithms | 16 | 2023 | 1918 | 0.710 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 32 | 0.710 |
Why?
|
| Hyperphagia | 1 | 2020 | 36 | 0.710 |
Why?
|
| Dipeptides | 1 | 2020 | 42 | 0.700 |
Why?
|
| Sensitivity and Specificity | 27 | 2015 | 2019 | 0.700 |
Why?
|
| Hypothalamus | 1 | 2020 | 79 | 0.690 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2016 | 402 | 0.680 |
Why?
|
| Reading | 1 | 2020 | 31 | 0.670 |
Why?
|
| Eating | 1 | 2020 | 168 | 0.660 |
Why?
|
| Image Enhancement | 7 | 2016 | 566 | 0.640 |
Why?
|
| Humans | 81 | 2024 | 90536 | 0.640 |
Why?
|
| Oxides | 4 | 2012 | 43 | 0.640 |
Why?
|
| Ferric Compounds | 4 | 2012 | 40 | 0.630 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2019 | 25 | 0.630 |
Why?
|
| Iron | 4 | 2012 | 173 | 0.610 |
Why?
|
| Mass Chest X-Ray | 1 | 2018 | 5 | 0.600 |
Why?
|
| Brain | 7 | 2019 | 2317 | 0.590 |
Why?
|
| Awards and Prizes | 3 | 2024 | 36 | 0.590 |
Why?
|
| Calcinosis | 6 | 2011 | 230 | 0.590 |
Why?
|
| Radiography, Abdominal | 1 | 2018 | 70 | 0.580 |
Why?
|
| Learning | 2 | 2021 | 287 | 0.560 |
Why?
|
| Patient Positioning | 1 | 2017 | 65 | 0.550 |
Why?
|
| Diagnostic Errors | 2 | 2017 | 160 | 0.540 |
Why?
|
| Signal-To-Noise Ratio | 4 | 2020 | 109 | 0.540 |
Why?
|
| Bone Neoplasms | 2 | 2011 | 321 | 0.540 |
Why?
|
| Radiation Exposure | 1 | 2016 | 25 | 0.540 |
Why?
|
| Knee Joint | 1 | 2017 | 168 | 0.530 |
Why?
|
| User-Computer Interface | 4 | 2012 | 187 | 0.530 |
Why?
|
| Codes of Ethics | 1 | 2016 | 12 | 0.520 |
Why?
|
| Safety | 1 | 2016 | 144 | 0.520 |
Why?
|
| Alzheimer Disease | 3 | 2018 | 518 | 0.510 |
Why?
|
| Data Mining | 1 | 2016 | 44 | 0.500 |
Why?
|
| Congresses as Topic | 1 | 2016 | 116 | 0.500 |
Why?
|
| Accidents | 1 | 2015 | 8 | 0.490 |
Why?
|
| Aged | 26 | 2024 | 19382 | 0.470 |
Why?
|
| Pandemics | 1 | 2021 | 788 | 0.470 |
Why?
|
| Language | 1 | 2016 | 157 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1356 | 0.460 |
Why?
|
| Gadolinium DTPA | 2 | 2012 | 256 | 0.450 |
Why?
|
| Breast Diseases | 3 | 2009 | 101 | 0.450 |
Why?
|
| Breast Neoplasms | 11 | 2012 | 3019 | 0.450 |
Why?
|
| Time Factors | 1 | 2023 | 5364 | 0.440 |
Why?
|
| Abbreviations as Topic | 1 | 2013 | 1 | 0.440 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2012 | 602 | 0.440 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2019 | 315 | 0.430 |
Why?
|
| Technology | 2 | 2024 | 31 | 0.430 |
Why?
|
| Japan | 7 | 2024 | 305 | 0.430 |
Why?
|
| Research Report | 1 | 2013 | 43 | 0.420 |
Why?
|
| Reproducibility of Results | 19 | 2012 | 2782 | 0.410 |
Why?
|
| Aged, 80 and over | 16 | 2018 | 6807 | 0.410 |
Why?
|
| Communication | 1 | 2016 | 462 | 0.400 |
Why?
|
| Chickens | 4 | 2021 | 212 | 0.400 |
Why?
|
| Lung Diseases | 5 | 2007 | 276 | 0.380 |
Why?
|
| Ethics, Research | 1 | 2012 | 52 | 0.370 |
Why?
|
| Radiology Information Systems | 1 | 2012 | 80 | 0.370 |
Why?
|
| Ultrasonography, Mammary | 1 | 2012 | 83 | 0.370 |
Why?
|
| Female | 35 | 2024 | 46830 | 0.360 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 24 | 0.360 |
Why?
|
| Patients | 1 | 2012 | 104 | 0.360 |
Why?
|
| Health Physics | 3 | 2024 | 21 | 0.360 |
Why?
|
| Radiography | 3 | 2022 | 809 | 0.360 |
Why?
|
| Logistic Models | 1 | 2014 | 1216 | 0.360 |
Why?
|
| Anniversaries and Special Events | 2 | 2022 | 15 | 0.350 |
Why?
|
| Middle Aged | 22 | 2024 | 26305 | 0.350 |
Why?
|
| Computer Terminals | 2 | 2010 | 7 | 0.350 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 192 | 0.340 |
Why?
|
| Male | 26 | 2024 | 42911 | 0.300 |
Why?
|
| Clinical Competence | 6 | 2011 | 796 | 0.280 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 781 | 0.280 |
Why?
|
| Area Under Curve | 4 | 2019 | 338 | 0.280 |
Why?
|
| Diagnosis, Differential | 11 | 2016 | 1607 | 0.260 |
Why?
|
| Contrast Media | 7 | 2016 | 1085 | 0.250 |
Why?
|
| Adult | 15 | 2024 | 26921 | 0.240 |
Why?
|
| Databases, Factual | 5 | 2024 | 875 | 0.230 |
Why?
|
| Radiation Protection | 1 | 2024 | 27 | 0.230 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2023 | 22 | 0.220 |
Why?
|
| Genotype | 2 | 2019 | 1855 | 0.220 |
Why?
|
| Research | 3 | 2016 | 252 | 0.220 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2011 | 269 | 0.200 |
Why?
|
| History, 20th Century | 2 | 2022 | 315 | 0.190 |
Why?
|
| Citrulline | 1 | 2021 | 10 | 0.180 |
Why?
|
| Heat Stress Disorders | 1 | 2021 | 12 | 0.180 |
Why?
|
| Artifacts | 2 | 2013 | 246 | 0.180 |
Why?
|
| Mass Screening | 1 | 2005 | 646 | 0.180 |
Why?
|
| Liver | 3 | 2010 | 1216 | 0.170 |
Why?
|
| Organizations | 1 | 2020 | 17 | 0.170 |
Why?
|
| Young Adult | 3 | 2018 | 6412 | 0.160 |
Why?
|
| Matched-Pair Analysis | 1 | 2019 | 40 | 0.160 |
Why?
|
| Automation | 2 | 2018 | 112 | 0.160 |
Why?
|
| Adolescent | 3 | 2018 | 9340 | 0.160 |
Why?
|
| Spine | 1 | 2019 | 102 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2019 | 185 | 0.150 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2017 | 33 | 0.150 |
Why?
|
| Computers | 2 | 2016 | 111 | 0.140 |
Why?
|
| Abdomen | 1 | 2018 | 125 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2021 | 1499 | 0.140 |
Why?
|
| Software Design | 1 | 2017 | 17 | 0.140 |
Why?
|
| Psychophysics | 2 | 2008 | 80 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2020 | 349 | 0.140 |
Why?
|
| Spinal Fractures | 2 | 2008 | 81 | 0.140 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 1066 | 0.130 |
Why?
|
| X-Rays | 1 | 2016 | 138 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 176 | 0.130 |
Why?
|
| Pattern Recognition, Visual | 2 | 2008 | 155 | 0.130 |
Why?
|
| Conflict of Interest | 1 | 2016 | 68 | 0.120 |
Why?
|
| Stroke, Lacunar | 1 | 2015 | 4 | 0.120 |
Why?
|
| Risk Management | 1 | 2015 | 44 | 0.120 |
Why?
|
| Osteoporosis | 2 | 2006 | 122 | 0.120 |
Why?
|
| Prognosis | 2 | 2021 | 3810 | 0.120 |
Why?
|
| Angiography | 1 | 2015 | 208 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2016 | 591 | 0.110 |
Why?
|
| False Positive Reactions | 4 | 2007 | 223 | 0.110 |
Why?
|
| Transcriptome | 1 | 2019 | 667 | 0.110 |
Why?
|
| Child | 2 | 2017 | 7215 | 0.110 |
Why?
|
| Sex Differentiation | 1 | 2013 | 9 | 0.110 |
Why?
|
| Chimera | 1 | 2013 | 56 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2011 | 4345 | 0.100 |
Why?
|
| Liquid Crystals | 2 | 2011 | 12 | 0.100 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2011 | 10 | 0.100 |
Why?
|
| Radiology Department, Hospital | 1 | 2012 | 25 | 0.100 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 78 | 0.090 |
Why?
|
| Reproduction | 1 | 2013 | 200 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 110 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 126 | 0.090 |
Why?
|
| Taste Buds | 1 | 2010 | 1 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 198 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 354 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 340 | 0.080 |
Why?
|
| Expert Systems | 1 | 2009 | 18 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 651 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 974 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 303 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2016 | 2335 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 220 | 0.080 |
Why?
|
| Lung | 5 | 2006 | 1305 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 259 | 0.080 |
Why?
|
| Movement | 1 | 2011 | 315 | 0.080 |
Why?
|
| Professional Competence | 1 | 2008 | 69 | 0.080 |
Why?
|
| Microbubbles | 1 | 2008 | 39 | 0.070 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2008 | 81 | 0.070 |
Why?
|
| Medical Oncology | 2 | 2008 | 381 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 168 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2007 | 58 | 0.070 |
Why?
|
| Animals | 4 | 2021 | 27690 | 0.070 |
Why?
|
| Fractures, Compression | 1 | 2006 | 17 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2018 | 161 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 88 | 0.070 |
Why?
|
| Aging | 1 | 2011 | 727 | 0.060 |
Why?
|
| Nerve Net | 2 | 2008 | 378 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2006 | 575 | 0.060 |
Why?
|
| Review Literature as Topic | 2 | 2018 | 20 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2012 | 3765 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 77 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2005 | 164 | 0.060 |
Why?
|
| Thoracic Neoplasms | 1 | 2003 | 66 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2024 | 87 | 0.050 |
Why?
|
| Physics | 1 | 2023 | 21 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1129 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 474 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 298 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 308 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 2519 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2016 | 9310 | 0.050 |
Why?
|
| Hormones | 1 | 2021 | 139 | 0.040 |
Why?
|
| United States | 3 | 2012 | 7141 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2021 | 207 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 671 | 0.040 |
Why?
|
| Atrophy | 1 | 2018 | 124 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 130 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 289 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 2667 | 0.030 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 418 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 157 | 0.030 |
Why?
|
| International Cooperation | 1 | 2016 | 126 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2016 | 121 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 377 | 0.030 |
Why?
|
| Semen | 1 | 2013 | 13 | 0.030 |
Why?
|
| Ovulation | 1 | 2013 | 68 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2013 | 35 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2013 | 50 | 0.030 |
Why?
|
| Luteinizing Hormone | 1 | 2013 | 167 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2013 | 62 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 230 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 108 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 143 | 0.020 |
Why?
|
| Estradiol | 1 | 2013 | 250 | 0.020 |
Why?
|
| Punctures | 1 | 2011 | 30 | 0.020 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2011 | 168 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 167 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 211 | 0.020 |
Why?
|
| Carboplatin | 1 | 2011 | 311 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 328 | 0.020 |
Why?
|
| Quinine | 1 | 2010 | 6 | 0.020 |
Why?
|
| Taste Perception | 1 | 2010 | 4 | 0.020 |
Why?
|
| Neurons | 2 | 2013 | 1593 | 0.020 |
Why?
|
| Food Preferences | 1 | 2010 | 27 | 0.020 |
Why?
|
| Taste | 1 | 2010 | 28 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 122 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 233 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 383 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2011 | 484 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 599 | 0.020 |
Why?
|
| Software Validation | 1 | 2008 | 3 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 690 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2008 | 125 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 845 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 959 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 898 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1741 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2006 | 372 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 121 | 0.010 |
Why?
|
| Mobile Health Units | 1 | 2003 | 11 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 70 | 0.010 |
Why?
|
| Quality Control | 1 | 2003 | 117 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 878 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1873 | 0.010 |
Why?
|